GlassScriptPhysician profile
Kelsey Guth
NPI 1992188114
$8,066.98
in general payments reported to CMS, 2019-2025
15 companies · $3,300 in 2025
The $3,300 reported for 2025 was more than what 98% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,046 · 2020: $17.24 · 2021: $53.70 · 2022: $209 · 2023: $1,691 · 2024: $750 · 2025: $3,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,541 · Travel and Lodging: $1,665 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Entertainment: $35.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,541.13 |
| Travel and Lodging | $1,664.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Entertainment | $35.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,585.76 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $2,883.67 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $214.18 | 2019 | |
| Sun Pharmaceutical Industries INC. | $195.23 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $184.82 | 2024-2025 | Xdemvy |
| Alimera Sciences, INC. | $163.69 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $149.28 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $139.83 | 2023-2025 | Miebo, Xiidra, Infuse |
| Lkc Technologies, INC. | $127.34 | 2024 | |
| Allergan, INC. | $125.14 | 2019 | |
| Abbvie INC. | $123.88 | 2025 | |
| Genzyme Corporation | $104.22 | 2019 | |
| Optos, INC. | $35.24 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $17.46 | 2023 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Guth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.